Global Gastrointestinal Drugs Market Analysis


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 157

  • Format: PPT, PDF

Global Gastrointestinal Drugs Market: Segmented by Drug Type (Antacids, Laxatives, Antidiarrheal agents, Antiemetic’s, Antiulcer agents and Other Drugs Type), Dosage Form (Oral, Parenteral and Other Dosage Forms), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America) – Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The global gastrointestinal drugs market size stood at around USD 42 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The major factors that contribute to the growth of the gastrointestinal drugs market include the increasing prevalence of gastrointestinal diseases due to unhealthy dietary habits, additional numbers of clinical trials with accurate results, increasing healthcare expenditure, and growth in the geriatric population.

Market Drivers

According to the National Health Interview Survey (2017), 15.3 million adults were diagnosed with ulcers in the United States. Therefore a wide range of new generation drugs is found targeting that include novel small molecules and cellular therapy are currently under investigation. Other driving factors include the rising surgical treatments and hospitalizations, due to GI diseases, and increasing R&D investments by biopharmaceutical companies in developing biologics and biosimilar.

However, risk factors, such as those related to the physiological, behavioural, psychosocial, and socio-environmental aspects, restrict the populations from reporting the diseases early, which reflects the low awareness and the economic burden. These risk factors and the increasing number of patent expirations restrict the growth of the gastrointestinal drugs market.

Major Gastrointestinal Disease

Ulcerative Colitis is found to witness healthy CAGR over the forecast period. Ulcerative colitis is found to witness rapid growth in the gastrointestinal drugs market. The growth of this segment can be attributed to the easy availability of drugs in the market to treat this condition. The segment is also anticipated to grow at a considerable rate owing to high clinical urgency to curb the growing prevalence of ulcerative colitis. This high prevalence is due to poor prognosis and consumption of unhealthy food, which may result in a high probability of disease recurrence. In addition, Takeda Pharmaceuticals, Jassen Pharmaceuticals, and Pfizer are among the major global companies that have established themselves with their products for the treatment of inflammatory ulcerative colitis.

1. Global Gastrointestinal Drugs Market Overview………………………………
A. Market Size
2. Market Growth Drivers……………………………………………………………..
A. Increasing Prevalence of GI Disease
B. Rising Investments in R&D by Pharmaceutical Companies
3. Major Gastrointestinal Diseases………………………………………………….
A. Ulcerative Colitis
B. Irritable Bowel Syndrome
C. Crohn’s Disease
D. Celiac Disease
E. Gastroenteritis
F. Others
4. Gastrointestinal Drugs Market Segmentation………………………………………
A. Drug Type
I. Antacids
II. Laxatives
III. Antidiarrheal agents
IV. Antiemetics
V. Antiulcer agents
VI. Other Drugs Types
B. Dosage Form
I. Oral
II. Parenteral
III. Other Dosage Forms
C. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. South America Market Analysis
5. Gastrointestinal Major Products Market Share………………………………….
A. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape………………………………………………………………..
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Abbott Company overview, Product & Services, Strategies & Financials
B. Takeda Company overview, Product & Services, Strategies & Financials
C. Astellas Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Gastrointestinal drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Type:

On the basis of drug type, the global gastrointestinal drugs market can be segmented into antacids, laxatives, antidiarrheal agents, antiemetic’s, antiulcer agents and other drugs.

By Dosage Form:

On the basis of dosage form, the global gastrointestinal drugs market can be segmented into oral, parental and other dosage forms.

By Region:

The global gastrointestinal drugs market can be segmented by region into North America, Europe, Asia-Pacific, Middle-East & Africa and South America.

Asia-Pacific is the Fastest Growing Region in the Gastrointestinal Drugs Market. In recent years, the Asian countries have been witnessing a similar growth trend to that of the western developed markets, particularly owing to the increasing economic growth, along with the privatization, competitive site experience, technological expertise, infrastructure, and the scale to manage large-scale clinical trials across India, China, Japan, South Korea, and other countries. The unmet medical need and potential market opportunity have accelerated the partnerships between major global companies and Asian pharmaceutical companies, for the development and exploration of commercial potential in the growth of the pharmaceutical business.

The North America market has also been accounted for the largest share and is expected to maintain its position during the forecast period. This substantial share can be attributed to unprecedented change in lifestyle, resulting in greater incidence of gastrointestinal diseases.

Top 5 Major Players

The major players in the gastrointestinal therapeutics market include Abbott, Allergan, GlaxoSmithKline PLC, Pfizer, and Takeda Pharmaceutical Company Limited, among others. These key players have extensively employed competition sustainability strategies such as new product development and regional and distribution channel expansion to gain a higher share in the market. Moreover, increased focus on refining operation and supply chain management has facilitated key players to maintain a competitive edge.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements